An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

M Sobas; P Montesinos; B Boluda; T Bernal; E Vellenga; J Nomdedeu; Bob Löwenberg; Pieter Sonneveld; MB Zijlmans; M Protivankova; J Scwarz

doi:10.1080/10428194.2018.1516875

An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

M Sobas, P Montesinos, B Boluda, T Bernal, E Vellenga, J Nomdedeu, Bob Löwenberg, Pieter Sonneveld, MB Zijlmans, M Protivankova, J Scwarz

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1030-1035
Number of pages	6
Journal	Leukemia & Lymphoma
Volume	60
Issue number	4
DOIs	https://doi.org/10.1080/10428194.2018.1516875
Publication status	Published - 2019

Access to Document

10.1080/10428194.2018.1516875

http://hdl.handle.net/1765/111411

Cite this

Sobas, M., Montesinos, P., Boluda, B., Bernal, T., Vellenga, E., Nomdedeu, J., Löwenberg, B., Sonneveld, P., Zijlmans, MB., Protivankova, M., & Scwarz, J. (2019). An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens. Leukemia & Lymphoma, 60(4), 1030-1035. https://doi.org/10.1080/10428194.2018.1516875

@article{730bfc8fc81c4680bfd55c47009dfead,

title = "An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens",

author = "M Sobas and P Montesinos and B Boluda and T Bernal and E Vellenga and J Nomdedeu and Bob L{\"o}wenberg and Pieter Sonneveld and MB Zijlmans and M Protivankova and J Scwarz",

year = "2019",

doi = "10.1080/10428194.2018.1516875",

language = "Undefined/Unknown",

volume = "60",

pages = "1030--1035",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "4",

}

Sobas, M, Montesinos, P, Boluda, B, Bernal, T, Vellenga, E, Nomdedeu, J, Löwenberg, B , Sonneveld, P, Zijlmans, MB, Protivankova, M & Scwarz, J 2019, 'An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens', Leukemia & Lymphoma, vol. 60, no. 4, pp. 1030-1035. https://doi.org/10.1080/10428194.2018.1516875

TY - JOUR

T1 - An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

AU - Sobas, M

AU - Montesinos, P

AU - Boluda, B

AU - Bernal, T

AU - Vellenga, E

AU - Nomdedeu, J

AU - Löwenberg, Bob

AU - Sonneveld, Pieter

AU - Zijlmans, MB

AU - Protivankova, M

AU - Scwarz, J

PY - 2019

Y1 - 2019

U2 - 10.1080/10428194.2018.1516875

DO - 10.1080/10428194.2018.1516875

M3 - Article

VL - 60

SP - 1030

EP - 1035

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 4

ER -